Hjem › Spinal muskelatrofi › Texas › Lewisville
Kliniske studier for Spinal muskelatrofi i Lewisville, TX
4 studier for Spinal muskelatrofi søker deltakere på steder i og rundt Lewisville (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy
RekruttererFase 2
- Neurology Rare Disease Center, Flower Mound · 6 mi unna
A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy
RekruttererFase 2
- Neurology Rare Disease Center, Flower Mound · 6 mi unna
A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in Babies With Genetically Diagnosed Spinal Muscular Atrophy (SMA)
RekruttererFase 3
- Neurology Rare Disease Center, Flower Mound · 6 mi unna
A Study to Learn About the Safety and Effects of Salanersen (BIIB115) When Given to Babies With Spinal Muscular Atrophy (SMA) Who Were Previously Treated With Onasemnogene Abeparvovec
RekruttererFase 3
- Neurology Rare Disease Center, Flower Mound · 6 mi unna
Spinal muskelatrofi-studier i andre byer
- New York City, NY9 studier
- Mountain View, CA9 studier
- Philadelphia, PA7 studier
- Grand Rapids, MI6 studier
- Chicago, IL6 studier
- Norfolk, VA6 studier
- Houston, TX5 studier
- Boston, MA5 studier
- Phoenix, AZ4 studier
- Little Rock, AR4 studier
- Aurora, CO4 studier
- Memphis, TN3 studier
Andre studier i Lewisville
- Ulcerøs kolitt10 studier
- Crohns sykdom9 studier
- Type 2-diabetes5 studier
- Brystkreft5 studier
- Inflammatorisk tarmsykdom4 studier
- Fordøyelsessykdommer4 studier
- Makuladegenerasjon3 studier
- Kardiovaskulær sykdom3 studier
- Kolorektal kreft3 studier
- Geografisk atrofi3 studier
- Tripelnegativ brystkreft3 studier
- Lungesykdommer3 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.